Literature DB >> 27519941

High abundance of circulating megakaryocytic cells in chronic myeloid leukemia in Indian patients. Revisiting George Minot to re-interpret megakaryocytic maturation.

Mona Anand1, Biswadip Hazarika2, Lalit Kumar3, Rajive Kumar4, Anita Chopra5.   

Abstract

Circulating megakaryocytic cells abound in chronic myeloid leukemia (CML) seen in India and uniquely provide a setting for observing megakaryocytic maturation in the peripheral blood, a milieu not native to megakaryocytes. Peripheral blood megakaryocytic cells were studied in 324 cases of CML (235 chronic, 65 accelerated and 24 blastic phases). Two maturation themes were evident. Megakaryocytic blasts, especially in some cases of blast crisis, precociously make a foray into platelet formation and end up producing huge agranular or poorly granular cytoplasmic lobulated masses, that break off and come to lie in the circulation. This evidence of unsuccessful effort may exist, in a considerably attenuated form in chronic phase, alongside of the second major theme of megakaryocytic maturation centered around the familiar micromegakaryocyte, characteristic of the chronic phase. This cell is regarded as dysplastic, but produces morphologically normal platelets. The possibility that this occurs via a hitherto unstudied alternative path of platelet maturation that plays out in the peripheral blood, and the contrasting disorderly premature attempt of blasts to form platelets, represent exciting maturation processes that need further study. Our observations fortuitously constitute a revisit of the insightful exposition on the subject by George Minot nearly a century ago.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic myeloid leukemia; Megakaryocytopoiesis

Mesh:

Year:  2016        PMID: 27519941     DOI: 10.1016/j.bcmd.2016.05.003

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  2 in total

1.  Circulating Mature Megakaryocytes in an Unusual Case of BCR-ABL1-Positive CML.

Authors:  Saniya Sharma; Prashant Sharma; Man Updesh Singh Sachdeva; Jogeshwar Binota; Anil Sood; Pankaj Malhotra; Neelam Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2018-06-26       Impact factor: 0.900

Review 2.  The Blood Circulating Rare Cell Population. What is it and What is it Good For?

Authors:  Stefan Schreier; Wannapong Triampo
Journal:  Cells       Date:  2020-03-25       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.